Drugs / Alphanate SD/HT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00323856 | Apr 2003 → Dec 2018 | severe hemophilia A | Grifols Biologicals, LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alphanate SD/HT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00323856 ↗ |
| Modality | Protein / enzyme biologic | “Plasma-derived preparation of Factor VIII” NCT00323856 ↗ |